What is Bilastine?
Bilastine is a second-generation H1-receptor antagonist (antihistamine) used for treating allergic rhinitis and chronic urticaria, characterized by high selectivity for H1 receptors, non-sedating properties, and once-daily dosing at 20 mg.
Drug Classification and Mechanism
Bilastine belongs to the second-generation antihistamine class, which is generally preferred over first-generation agents for allergic conditions 1. The drug works through:
- Selective H1-receptor antagonism: Bilastine demonstrates potent and highly selective binding to histamine H1 receptors, with its carboxyl group contributing to increased receptor affinity through electrostatic interactions with specific amino acid residues (Lys179 and Lys191) 2
- Inverse agonist activity: Beyond blocking histamine, bilastine suppresses constitutive H1 receptor activity, reducing basal receptor gene expression and intracellular calcium oscillations—making it more potent than pure antagonists 3
- Anti-inflammatory properties: The drug exhibits effects beyond simple histamine blockade 4
Clinical Indications
Bilastine is approved for:
- Allergic rhinitis (both seasonal and perennial)
- Chronic spontaneous urticaria
- Symptomatic relief of rhinorrhea, sneezing, nasal itching, and nasal congestion 4, 5
Dosing and Administration
- Standard dose: 20 mg once daily orally 6, 7
- Dose escalation: Can be increased up to 4-fold (80 mg daily) in patients with inadequate control, following the "as much as needed and as little as possible" approach 8
- Administration: Should be taken in fasted state for optimal absorption 9
Pharmacokinetic Profile
- Elimination: Primarily renal excretion; bilastine is minimally metabolized with no significant active metabolites 9, 6
- Half-life: Allows for once-daily dosing 9
- Renal impairment: No dose adjustment required even in severe renal insufficiency (GFR ≤30 mL/min/1.73 m²), as exposure remains within safety margins despite increased AUC 6
Efficacy
Clinical evidence demonstrates that bilastine:
- Improves symptom scores: Significantly reduces Total Symptom Scores (TSS), Total Nasal Symptom Scores (TNSS), and Visual Analog Scores (VAS) compared to placebo 4
- Enhances quality of life: Substantial improvements in disease-specific QOL measures 4, 10
- Comparable to other antihistamines: Shows equivalent efficacy to cetirizine, fexofenadine, and loratadine 4, 5
- High response rates: In autoimmune chronic urticaria, 82.4% of patients achieved complete response by week 8, with 47.1% responding to standard dose 10
Safety Profile
Bilastine is non-sedating at recommended doses, distinguishing it from first-generation antihistamines and even some second-generation agents like cetirizine 1. Key safety features include:
- No sedation or performance impairment: Unlike fexofenadine, loratadine, and desloratadine, bilastine maintains this profile at standard doses 1
- No cardiotoxic effects: No QT prolongation reported in clinical trials and post-marketing surveillance 6
- Well-tolerated: Adverse event incidence comparable to placebo 4
- Safe in renal impairment: No dose adjustment needed across all degrees of renal function 6
Clinical Positioning
Within the treatment algorithm for allergic conditions:
- First-line option: Bilastine can be used as initial monotherapy for moderate-to-severe allergic rhinitis 11
- Step-up approach: If inadequate control with standard dose, increase up to 4-fold before adding other agents 8
- Combination therapy: May be combined with intranasal corticosteroids for enhanced symptom control 11
- Predictors of response: Normal/high IgE levels associated with better outcomes; basopenia, high baseline symptom scores, and autoimmune disease history predict poorer response 10
Important Caveats
- Food interaction: Absorption may be affected by food; administer in fasted state 9
- Limited pediatric data: Most studies conducted in adults; careful extrapolation needed for children 11
- Pregnancy: Like other antihistamines, best avoided during pregnancy, especially first trimester, though no teratogenic effects demonstrated 12